GeneNews Wins $2M to Validate Prostate Disease Markers, Develop Dx for Asian Consortium | GenomeWeb
NEW YORK (GenomeWeb News) — GeneNews today said it will pocket $2 million as part of a deal to develop and validate biomarkers for prostate diseases, including cancer, for an unnamed Asian biomedical consortium.
 
GeneNews said it will use its Sentinel Principle and Discovery Funnel technologies to find the biomarkers. If a biomarker panel is successfully validated, GeneNews will develop and market a blood-based diagnostic called ProstateSentry.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.